Comparison of two models of oxidative damage in H9C2 cardiomyocytes

Cheng Yunxia, Deng Hongrong, Liu Huiwen, Xu Hao, Yi Qin, Tan Bin, Tian Jie, Zhu Jin

PDF(3518 KB)
PDF(3518 KB)
Journal of Chongqing Medical University ›› 2024, Vol. 49 ›› Issue (09) : 1079-1085. DOI: 10.13406/j.cnki.cyxb.003585
Basic research

Comparison of two models of oxidative damage in H9C2 cardiomyocytes

Author information +
History +

Abstract

Objective To investigate the value of glucose and serum deprivation under hypoxia(1% O2)(GSDH) treatment and H2O2 treatment in establishing a model of oxidative injury in H9C2 cardiomyocytes. Methods H9C2 cardiomyocytes were cultured,and when the cardiomyocytes were in good growth conditions,they were treated with the combination of low oxygen(1% O2),low glucose(1.0 g/L),and serum deprivation or H2O2 200 μmol/L alone for 24 hours. CCK8 assay was sued to measure the proliferation ability of cells;the apoptosis reagent(AnnexinV-FITC/PI) and Hoechst staining were used to measure cell apoptosis;reactive oxygen species(ROS) was used to measure the level of oxidative stress;BODIPY testing was used to measure the level of lipid peroxidation in cells;periodic acid-Schiff staining was used to measure the ability for glycogen synthesis;mitochondrial membrane potential assay kit with JC-1 staining was used to measure mitochondrial membrane potential;Western blot was used to measure the protein expression levels of the energy metabolism-related molecule AMP-activated protein kinase(AMPK) and the oxidative stress-related molecules NAD(P)H quinone dehydrogenase 1(NQO-1) and heme oxygenase-1(HO-1). Results Compared with the blank group,both the GSDH treatment group and the H2O2 treatment group had a significant reduction in the viability of cardiomyocytes(P<0.05). Compared with the blank group,both GSDH treatment and H2O2 treatment increased the levels of cardiomyocyte apoptosis,ROS and lipid droplet accumulation,and glycogen consumption,with a reduction in mitochondrial membrane potential in cardiomyocytes. However,compared with the H2O2 treatment group,the GSDH treatment group showed significantly greater increases in glycogen consumption and lipid droplet accumulation and a significant reduction in AMPK phosphorylation. Conclusion Both GSDH treatment and H2O2 treatment can cause oxidative injury to H9C2 cardiomyocytes,but compared with H2O2 treatment,the effect of GSDH treatment is more in line with the energy metabolism transition during myocardial injury in vivo,and therefore,it is expected to be used as a simpler and more convenient model of oxidative injury to cardiac myocardium for scientific research.

Key words

glucose and serum deprivation under hypoxia / hydrogen peroxide / oxidative stress / energy metabolism / Western blot

Cite this article

Download Citations
Cheng Yunxia , Deng Hongrong , Liu Huiwen , et al . Comparison of two models of oxidative damage in H9C2 cardiomyocytes. Journal of Chongqing Medical University. 2024, 49(09): 1079-1085 https://doi.org/10.13406/j.cnki.cyxb.003585

References

1
Townsend N Kazakiewicz D Lucy Wright F,et al. Epidemiology of cardiovascular disease in Europe[J]. Nat Rev Cardiol202219(2):133-143.
2
Lolley R Forman DE. Cardiac rehabilitation and survival for ischemic heart disease[J]. Curr Cardiol Rep202123(12):184.
3
Karwi QG Sun QY Lopaschuk GD. The contribution of cardiac fatty acid oxidation to diabetic cardiomyopathy severity[J]. Cells202110(11):3259.
4
Masoli JAH Mensah E Rajkumar C. Age and ageing cardiovascular collection:blood pressure,coronary heart disease and heart failure[J]. Age Ageing202251(8):afac179.
5
Carley AN Maurya SK Fasano M,et al. Short-chain fatty acids outpace ketone oxidation in the failing heart[J]. Circulation2021143(18):1797-1808.
6
Lopaschuk GD Karwi QG Tian R,et al. Cardiac energy metabolism in heart failure[J]. Circ Res2021128(10):1487-1513.
7
Ranjbarvaziri S Kooiker KB Ellenberger M,et al. Altered cardiac energetics and mitochondrial dysfunction in hypertrophic cardiomyopathy[J]. Circulation2021144(21):1714-1731.
8
Zhao MM Wei HR Li CZ,et al. Gut microbiota production of trimethyl-5-aminovaleric acid reduces fatty acid oxidation and accelerates cardiac hypertrophy[J]. Nat Commun202213(1):1757.
9
Chen Z Jin ZX Cai JJ,et al. Energy substrate metabolism and oxidative stress in metabolic cardiomyopathy[J]. J Mol Med2022100(12):1721-1739.
10
Zhuang LF Jia KN Chen C,et al. DYRK1B-STAT3 drives cardiac hypertrophy and heart failure by impairing mitochondrial bioenergetics[J]. Circulation2022145(11):829-846.
11
Murashige D Jang C Neinast M,et al. Comprehensive quantification of fuel use by the failing and nonfailing human heart[J]. Science2020370(6514):364-368.
12
Dambrova M Zuurbier CJ Borutaite V,et al. Energy substrate metabolism and mitochondrial oxidative stress in cardiac ischemia/reperfusion injury[J]. Free Radic Biol Med2021165:24-37.
13
Li Y Ma Y Dang QY,et al. Assessment of mitochondrial dysfunction and implications in cardiovascular disorders[J]. Life Sci2022306:120834.
14
Wang X Chen XX Zhou WQ,et al. Ferroptosis is essential for diabetic cardiomyopathy and is prevented by sulforaphane via AMPK/NRF2 pathways[J]. Acta Pharm Sin B202212(2):708-722.
15
Feng YN Zhang YY Xiao H. AMPK and cardiac remodelling[J]. Sci China Life Sci201861(1):14-23.
16
Steinberg GR Hardie DG. New insights into activation and function of the AMPK[J]. Nat Rev Mol Cell Biol202324(4):255-272.
17
Cruz AM Partridge KM Malekizadeh Y,et al. Brain permeable AMP-activated protein kinase activator R481 raises glycaemia by autonomic nervous system activation and amplifies the counterregulatory response to hypoglycaemia in rats[J]. Front Endocrinol202112:697445.
18
Spaulding HR Yan Z. AMPK and the adaptation to exercise[J]. Annu Rev Physiol202284:209-227.
19
Popov SV Mukhomedzyanov AV Voronkov NS,et al. Regulation of autophagy of the heart in ischemia and reperfusion[J]. Apoptosis202328(1/2):55-80.
20
Yao MR Wang ZR Jiang LY,et al. Oxytocin ameliorates high glucose- and ischemia/reperfusion-induced myocardial injury by suppressing pyroptosis via AMPK signaling pathway[J]. Biomed Pharmacother2022153:113498.
21
Fouqueray P Bolze S Dubourg J,et al. Pharmacodynamic effects of direct AMP kinase activation in humans with insulin resistance and non-alcoholic fatty liver disease:a phase 1b study[J]. Cell Rep Med20212(12):100474.
22
Zhang Q Liu SD Zhang CS,et al. AMPK directly phosphorylates TBK1 to integrate glucose sensing into innate immunity[J]. Mol Cell202282(23):4519-4536.
23
Midha AD Zhou YY Queliconi BB,et al. Organ-specific fuel rewiring in acute and chronic hypoxia redistributes glucose and fatty acid metabolism[J]. Cell Metab202335(3):504-516.
24
Nielsen R Møller N Gormsen LC,et al. Cardiovascular effects of treatment with the ketone body 3-hydroxybutyrate in chronic heart failure patients[J]. Circulation2019139(18):2129-2141.

Comments

PDF(3518 KB)

Accesses

Citation

Detail

Sections
Recommended

/